Verily

By Dave Muoio May 6, 2019
The NIH’s All of Us Research Program celebrated its one-year anniversary today with new updates on enrollment progress, previews of its upcoming cloud-based data platform for health researchers and the public beta launch of an online tool for viewing aggregated, de-identified information about the program’s enrollees. “I hoped [one year ago] that many would share this vision and help us achieve...
By Laura Lovett March 15, 2019
When it comes to digital health, investors get a bird’s eye view and play a major role in steering the direction of the industry’s future. That is why many are stressing the importance of a diverse viewpoint for investors in an industry focused on bringing digital tools to the masses.  Traditionally this has been a challenge for the venture space, where women only account for 12.2 percent of...
By Laura Lovett February 25, 2019
Google has been busy recently. Just in the past week it has closed down its Google Fit website,  launched a new drug disposal tool and announced the first clinical use of Verily’s machine learning tool for diabetic related diseases.  Below is a look at three of the company’s digital health announcements in the last week.  Addressing the opioid crisis  It started last Wednesday when Google...
By Dave Muoio February 4, 2019
Verily's prototype smart shoe. Verily is shopping for partners to develop a smart shoe with embedded sensors for movement, weight and fall monitoring, according to a CNBC report citing three anonymous sources. The company allegedly has a prototype design of the footwear that it has been showing off in private meetings, and is envisioning the shoe as a health product. … MRIs are A-OK. Senseonics’...
By Laura Lovett January 18, 2019
This morning Alphabet’s life science subsidiary Verily announced that its Verily Study Watch and its on-demand ECG feature landed a 510(k) clearance from the FDA. The watch is a prescription-only device, and was designed to record, store, transfer and display single-channel ECG rhythms. The company said the device’s ability to take on-demand, single-lead ECG can be used for individual patient...
By Laura Lovett January 4, 2019
This morning Alphabet life science subsidiary Verily announced a staggering $1 billion in new venture funding led by Silver Lake, with participation from Ontario Teacher’s Pension Plan and other global investment management firms. As part of the deal, Silver Lake Managing Partner and Director Egon Durban will be nominated to the company’s operating board, as will Ruth Porat, chief financial...
By Dave Muoio December 20, 2018
Alphabet’s business interests cover a wide range of industries, and healthcare is certainly among them. With each passing year, Alphabet (or Google, or Verily) unveils a growing collection of tech-driven partnerships and healthcare tools — read on for a compilation of the company’s news in 2018. January 4: Cityblock Health, the urban-focused public health startup that spun out of Alphabet’s...
By Dave Muoio December 13, 2018
Onduo, a Verily-Sanofi joint venture focused on digitally-driven diabetes management, is looking to further protect its members from foot ulcers and limb loss. Orpyx Medical Technologies’ diabetic foot ulcer sensors for its members. Thanks to a newly announced deal struck between the companies, Orpyx Medical Technologies’ FDA-cleared SurroSense Rx system will be available to “select members” of...
NovioSense's artist conception of its device in use.

NovioSense's artist conception of its device in use.

By Jonah Comstock November 20, 2018
Last week, Alphabet subsidiary Verily Life Sciences announced the end, at least for the foreseeable future, of its glucose-sensing lens collaboration with Novartis. Verily CTO Brian Otis gave his thoughts in a blog post at the time, stressing the learnings the company got from the project. In a recent interview with Babyforyou.net.ua, Novartis Global Head of Digital Development Jacob LaPorte...
By Jonah Comstock November 16, 2018
Four years after announcing an ambitious — and often ridiculed — project to create a glucose-sensing lens along with Novartis subsidiary Alcon, Alphabet's Verily is throwing in the towel, the company announced in a blog post today. It will continue to work on two other medical lens projects, aimed at presbyopia and cataract surgery recovery. "Our clinical work on the glucose-...
http://steroid-pharm.com

www.steroid-pharm.com

dapoxetine acquistare